Ascentage Pharma Group International (AAPG) Non-Current Receivables (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Historic Non-Current Receivables for Ascentage Pharma Group International (AAPG) over the last 2 years, with Q4 2024 value amounting to $3.6 million.

• Ascentage Pharma Group International's Non-Current Receivables rose 27004.45% to $3.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.6 million, marking a year-over-year increase of 27004.45%. This contributed to the annual value of $3.6 million for FY2024, which is 25756.0% up from last year.
• Ascentage Pharma Group International's Non-Current Receivables amounted to $3.6 million in Q4 2024, which was up 27004.45% from $979433.9 recorded in Q4 2023.
• Ascentage Pharma Group International's Non-Current Receivables' 5-year high stood at $3.6 million during Q4 2024, with a 5-year trough of $979433.9 in Q4 2023.

Peer Comparison